Legal Representation
Attorney
DAVID A. JACKSON
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 7, 2019 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Aug 7, 2019 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 9, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 9, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 9, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 15, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 14, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 14, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 15, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 15, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 15, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 12, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 7, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 3, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific research, pharmaceutical research, medical research; technical and scientific consultation and product development services, including for others, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases; research and development of new products pertaining to the treatment of immune mediated diseases, inflammatory diseases, and rare diseases, and to pharmaceuticals; providing on line information for medical research purposes, in the fields of immune mediated diseases, inflammatory diseases, and rare diseases, treatments for immune mediated diseases, inflammatory diseases, and rare diseases, and pharmaceuticals
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"